X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (74) 74
humans (73) 73
male (70) 70
adult (50) 50
testicular cancer (49) 49
chemotherapy (44) 44
testicular neoplasms - pathology (41) 41
oncology (40) 40
cancer (35) 35
middle aged (31) 31
adolescent (29) 29
tumors (29) 29
prognosis (27) 27
surgery (27) 27
testicular neoplasms - drug therapy (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
non-seminomatous germ cell tumor (24) 24
urology & nephrology (24) 24
retrospective studies (23) 23
testicular neoplasms - surgery (22) 22
neoplasms, germ cell and embryonal - pathology (20) 20
follow-up studies (18) 18
lymph-node dissection (18) 18
adjuvant chemotherapy (17) 17
neoplasms, germ cell and embryonal - surgery (17) 17
seminoma (17) 17
teratoma (17) 17
testicular neoplasms - therapy (17) 17
germinoma - pathology (16) 16
neoplasm staging (16) 16
orchiectomy (16) 16
surveillance (16) 16
management (15) 15
retroperitoneal lymph node dissection (15) 15
testis (15) 15
testis cancer (15) 15
combined modality therapy (14) 14
germ-cell tumors (14) 14
neoplasms, germ cell and embryonal - drug therapy (14) 14
non-seminomatous (14) 14
prognostic factors (14) 14
risk factors (14) 14
treatment outcome (14) 14
medicine & public health (13) 13
metastasis (13) 13
germinoma - drug therapy (12) 12
non-seminomatous germ cell tumors (12) 12
cisplatin (11) 11
etoposide (11) 11
non-seminomatous germ cell tumour (11) 11
survival analysis (11) 11
cisplatin - administration & dosage (10) 10
survival (10) 10
survival rate (10) 10
young adult (10) 10
antineoplastic agents - therapeutic use (9) 9
chemotherapy, adjuvant (9) 9
experience (9) 9
lymph node excision - methods (9) 9
neoplasms, germ cell and embryonal - therapy (9) 9
non-seminomatous germ cell tumours (9) 9
radiotherapy (9) 9
teratoma - pathology (9) 9
testicular neoplasms - mortality (9) 9
alpha-fetoproteins - analysis (8) 8
bleomycin (8) 8
diagnosis (8) 8
disease-free survival (8) 8
neoplasms, germ cell and embryonal - mortality (8) 8
testicular neoplasms - diagnosis (8) 8
aged (7) 7
bleomycin - administration & dosage (7) 7
cisplatin - therapeutic use (7) 7
combination chemotherapy (7) 7
etoposide - administration & dosage (7) 7
germ cell tumors (7) 7
germinoma - therapy (7) 7
high-dose chemotherapy (7) 7
metastases (7) 7
neoplasm recurrence, local (7) 7
risk (7) 7
seminoma - drug therapy (7) 7
urology (7) 7
analysis (6) 6
biomarkers, tumor - blood (6) 6
brain neoplasms - secondary (6) 6
embryonal carcinoma (6) 6
follow-up (6) 6
germinoma - secondary (6) 6
lung neoplasms - secondary (6) 6
multivariate analysis (6) 6
neoplasms, germ cell and embryonal - secondary (6) 6
relapse (6) 6
retroperitoneal (6) 6
retroperitoneal space (6) 6
testicular neoplasms (6) 6
vascular invasion (6) 6
brain metastases (5) 5
carboplatin (5) 5
diagnosis, differential (5) 5
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (106) 106
French (10) 10
German (7) 7
Spanish (4) 4
Japanese (3) 3
Russian (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BJU International, ISSN 1464-4096, 09/2019, Volume 124, Issue 3, pp. 424 - 430
Journal Article
Oncology Letters, ISSN 1792-1074, 11/2014, Volume 8, Issue 5, pp. 2179 - 2182
Germ cell tumors (GCTs) comprise 95% of malignant tumors arising in the testes. The present study reports a patient diagnosed with non-seminomatous testicular... 
Non‑seminomatous germ cell tumor | Late relapse | Multiple sclerosis | β‑interferon | Inmunosupression
Journal Article
Journal Article
ONCOLOGY LETTERS, ISSN 1792-1074, 11/2014, Volume 8, Issue 5, pp. 2179 - 2182
Germ cell tumors (GCTs) comprise 95% of malignant tumors arising in the testes. The present study reports a patient diagnosed with non-seminomatous testicular... 
GERM-CELL CANCER | non-seminomatous germ cell tumor | MANAGEMENT | late relapse | multiple sclerosis | inmunosupression | beta-interferon | TUMORS | SALVAGE CHEMOTHERAPY | SUPPORT | ETOPOSIDE | CISPLATIN | ONCOLOGY | DISEASE | EXPERIENCE
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2011, Volume 38, Issue 2, pp. 323 - 333
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 02/2011, Volume 38, Issue 2, pp. 323 - 333
Journal Article
CURRENT OPINION IN UROLOGY, ISSN 0963-0643, 11/2003, Volume 13, Issue 6, pp. 473 - 476
Purpose of review To review current developments in the management of patients with testicular cancer, with special emphasis on risk factors for the primary... 
LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | PROGNOSTIC FACTORS | risk factors | non-seminomatous disease | SURVEILLANCE FOLLOWING ORCHIECTOMY | GERM-CELL TUMORS | FOLLOW-UP | SINGLE-AGENT CARBOPLATIN | TESTIS | UROLOGY & NEPHROLOGY | germ cell tumours | treatment options for clinical stage I disease | EXPERIENCE | seminoma
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0121300 - e0121300
Background Expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate with favourable clinicopathological parameters and prognosis in... 
DIAGNOSIS | GROUP EGCCCG | TUMOR PROGRESSION | EUROPEAN CONSENSUS CONFERENCE | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | UPDATE | INTERMEDIATE-RISK | DECREASED EXPRESSION | CHEMOTHERAPY | Immunohistochemistry | Multivariate Analysis | Recurrence | Prognosis | Humans | Risk Factors | Proportional Hazards Models | Testicular Neoplasms - metabolism | Male | Neoplasms, Germ Cell and Embryonal - metabolism | Testicular Neoplasms - pathology | Young Adult | Disease-Free Survival | Treatment Failure | Adolescent | Adult | Neoplasm Staging | Neoplasms, Germ Cell and Embryonal - pathology | RNA-Binding Proteins - metabolism | RNA | Cancer | Protein binding | Correlation | Medical services | Oncology | Tissue analysis | Metastasis | Testicular cancer | Cancer therapies | Ovarian cancer | Metastases | Skin cancer | Proteins | Classification | Bioindicators | Failure | Medical research | Parameters | Melanoma | Hazards | Regression analysis | Statistical tests | Gene expression | Ribonucleic acid--RNA | Patients | Bladder cancer | Survival | Pathology | Chemotherapy | Statistical models | Councils | Medical prognosis | Biomarkers | Protein expression | Testes | Tumors | Index Medicus | unclassified drug | patient assessment | risk assessment | RNA binding motif protein 3 | cancer specific survival | Medical and Health Sciences | Medicin och hälsovetenskap | tissue microarray | major clinical study | Article | metastasis | treatment failure | immunohistochemistry | human | protein expression | high risk patient | failure free survival | human tissue | Medicinsk bioteknologi | RNA binding protein | aged | cancer prognosis | clinical feature | Medical Biotechnology | cancer staging | controlled study | prediction | down regulation | adult | non seminomatous germinoma | male | Ribonucleic acid
Journal Article
Journal Article
Revisiones en Cancer, ISSN 0213-8573, 2017, Volume 31, Issue 1, pp. 19 - 29
Journal Article
Onkologie (Czech Republic), ISSN 1802-4475, 2016, Volume 10, Issue 4, pp. 159 - 159
Journal Article
Asian Journal of Andrology, ISSN 1008-682X, 07/2013, Volume 15, Issue 4, pp. 558 - 563
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.